Concepedia

J.G.M. Klijn

JK

36

Publications

3.4K

Citations

25

H-Index

1984

Active since

Affiliations

Rotterdam University of Applied Sciences(Current)

Erasmus University Rotterdam

Erasmus MC Cancer Institute

University of Amsterdam

University Hospital of Bern

J.G.M. Klijn is an author at Rotterdam University of Applied Sciences specializing in medicine, breast cancer, and oncology.

Top concepts

Publications per year

1984–2008

36

Publications

36

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1

L.C. Verhoog, CTM Brekelmans, Caroline Seynaeve et al. · The Lancet · 1998 · 452 citations

, , +9

High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer.

John A. Foekens, Harry A. Peters, Nicolaï Grebenchtchikov et al. · PubMed · 2001 · 300 citations

, , +18

Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients.

John A. Foekens, Manfred Schmitt, W L van Putten et al. · PubMed · 1992 · 231 citations

, , +14

Plasminogen activator inhibitor-1 and prognosis in primary breast cancer.

John A. Foekens, Manfred Schmitt, W L van Putten et al. · Journal of Clinical Oncology · 1994 · 225 citations

c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer.

E. Berns, J.G.M. Klijn, W L van Putten et al. · PubMed · 1992 · 206 citations

, , +13

Rows per page

1–5 of 36